A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S‐1 in patients with stage II‐IIIA non‐small cell lung cancer-Reference-Cited by-同舟云学术

A feasibility study of postoperative adjuvant chemotherapy with fluoropyrimidine S‐1 in patients with stage II‐IIIA non‐small cell lung cancer

Published:2018 Issue:1.2 Volume:65 Page:90-95
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Tsuboi Mitsuhiro¹,Kondo Kazuya²,Takizawa Hiromitsu¹,Kawakita Naoya¹,Sawada Toru¹,Toba Hiroaki¹,Kawakami Yukikiyo¹,Yoshida Mitsuteru¹,Ishikura Hisashi³,Kimura Suguru⁴,Tangoku Akira¹

Affiliation:

1. Department of Thoracic, Endocrine Surgery and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School

2. Department of Oncological Medical Services, Institute of Biomedical Sciences, Tokushima University Graduate School

3. Department of general thoracic surgery, Tokushima Red Cross Hospital

4. Department of surgery, East Tokushima Medical Center

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/65/1.2/65_90/_pdf

Reference19 articles.

1. 1. Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal:Cancer statics. CA Cancer J Clin 63:11‐30, 2013

2. 2. Arriagada R, Bergman B, Dunant A, et al:Cisplatin‐based adjuvant chemotherapy for completely resected non‐small‐cell‐lung cancer. N Engl J Med 350:351‐360, 2004

3. 3. Winton T, Livingston R, Johnson D, et al:Vinorelbine plus cisplatin vs. observation in resected non‐small‐cell lung cancer. N Engl J Med 352:2589‐2597, 2005

4. 4. Douillard JY, Rosell R, De Lena M, et al:Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage roman I B‐roman I back 10 roman I back 20 roman I A non‐small‐cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):a randomised controlled trial. Lancet Oncol 7:719‐7727, 2006

5. 5. Pignon JP, Tribodet H, Scagliotti GV, et al:Lung adjuvant cisplatin evaluation:a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552‐3559, 2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301;BMC Cancer;2021-05-06

2. A pilot study of adjuvant chemotherapy with carboplatin and oral S‐1 for patients with completely resected stage II to IIIA non‐small cell lung cancer;Thoracic Cancer;2020-04-29

3. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1;Thoracic Cancer;2018-08-20